Home > Idera Pharmaceuticals Salary

Idera Pharmaceuticals Salary

  • 94
  • 89
  • 93
Idera Pharmaceuticals average salary is $75,000, median salary is $75,000 with a salary range from $75,000 to $75,000.
Idera Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Idera Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
75,000
Average
75,000
Median
75,000
High
75,000
Total 1 Idera Pharmaceuticals Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Idera Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Idera Pharmaceuticals Jobs
See more Idera Pharmaceuticals Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Idera Pharmaceuticals... Information
  • Idera Pharmaceuticals, Inc
  • Industry: Biotech/Healthcare
  • City: Cambridge, MA
  • Idera Pharmaceuticals, Inc. (AMEX: IDP) is a biotechnology company engaged in the discovery and development of novel therapeutics that modulate immune responses through Toll-like receptors (TLR) for the treatment of multiple diseases. We have identified proprietary DNA-based structures that modulate TLR, which is one of the most promising new approaches in drug development. Our immune modulatory oligonucleotide (IMO?) compounds are broadly applicable to large and growing markets where significant unmet medical needs exist, including oncology, asthma/allergy, and infectious diseases. We continue to identify new drug candidates specific to various diseases, based on the differentiated biological activities of our IMO? compounds.